Back to School: How biopharma can reboot drug development. Access exclusive analysis here

MBI 853NL: Began Phase I trial

Micrologix Biotech Inc. (TSE:MBI; MGIXF), Vancouver, B.C.
Product:

Read the full 80 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE